TY - JOUR
T1 - Implementation of a Medication Reconciliation Assistive Technology
T2 - A Qualitative Analysis
AU - Wright, Theodore B.
AU - Adams, Kathleen
AU - Church, Victoria L.
AU - Ferraro, Mimi
AU - Ragland, Scott
AU - Sayers, Anthony
AU - Tallett, Stephanie
AU - Lovejoy, Travis
AU - Ash, Joan
AU - Holahan, Patricia J.
AU - Lesselroth, Blake J.
PY - 2017
Y1 - 2017
N2 - Objective: To aid the implementation of a medication reconciliation process within a hybrid primary-specialty care setting by using qualitative techniques to describe the climate of implementation and provide guidance for future projects. Methods: Guided by McMullen et al's Rapid Assessment Process1, we performed semi-structured interviews prior to and iteratively throughout the implementation. Interviews were coded and analyzed using grounded theory2 and cross-examined for validity. Results: We identified five barriers and five facilitators that impacted the implementation. Facilitators identified were process alignment with user values, and motivation and clinical champions fostered by the implementation team rather than the administration. Barriers included a perceived limited capacity for change, diverging priorities, and inconsistencies in process standards and role definitions. Discussion: A more complete, qualitative understanding of existing barriers and facilitators helps to guide critical decisions on the design and implementation of a successful medication reconciliation process.
AB - Objective: To aid the implementation of a medication reconciliation process within a hybrid primary-specialty care setting by using qualitative techniques to describe the climate of implementation and provide guidance for future projects. Methods: Guided by McMullen et al's Rapid Assessment Process1, we performed semi-structured interviews prior to and iteratively throughout the implementation. Interviews were coded and analyzed using grounded theory2 and cross-examined for validity. Results: We identified five barriers and five facilitators that impacted the implementation. Facilitators identified were process alignment with user values, and motivation and clinical champions fostered by the implementation team rather than the administration. Barriers included a perceived limited capacity for change, diverging priorities, and inconsistencies in process standards and role definitions. Discussion: A more complete, qualitative understanding of existing barriers and facilitators helps to guide critical decisions on the design and implementation of a successful medication reconciliation process.
UR - http://www.scopus.com/inward/record.url?scp=85058738826&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058738826&partnerID=8YFLogxK
M3 - Article
C2 - 29854251
AN - SCOPUS:85058738826
SN - 1559-4076
VL - 2017
SP - 1802
EP - 1811
JO - AMIA ... Annual Symposium proceedings. AMIA Symposium
JF - AMIA ... Annual Symposium proceedings. AMIA Symposium
ER -